China update 2023: How will recent developments impact your brand’s success?
Register now for this webinar, in which our in-house experts explain the impact of the demographic shift, and the new policies that have been introduced in China.
Spotlight on Acute Graft Versus Host Disease (aGvHD)
Download this summary report to find out about therapies in clinical development, efficacy rates, unmet needs, and future potential opportunities for pharmaceutical companies in the aGvHD space.
Could combatting stigma increase the uptake of PrEP and finally end the HIV epidemic?
We explore what more could be done by the pharmaceutical industry to maximize treatment use, in order to help prevent the spread of HIV infection worldwide.
How we seamlessly transitioned a global brand tracker from an incumbent provider to deliver fresh insights
Our client wanted to transition from their existing brand tracking provider to a new market research partner that could bring fresh ideas and new approaches
Watch part two in a series, Evolving Patient Journeys, in which experts from across Inizio explore why, despite best intentions, patient engagement solutions can fall short of expectations.
In Volume 5 of our emerging markets magazine, our experts discuss a range of topics and trends across emerging markets which offer exciting opportunities.
How we supported the development and commercialization of a new gene therapy asset in the ophthalmology space
Find out how we helped our client to identify drivers and barriers of their new gene therapy asset, to guide further development and commercialization.
Download this summary report to find out about therapies in clinical development, efficacy rates, unmet needs, and future potential opportunities for pharmaceutical companies in the Myasthenia Gravis space.
Download this summary report to find out about therapies in clinical development, efficacy rates, unmet needs, and future potential opportunities for pharmaceutical companies in the Ulcerative Colitis space.
Download this summary report to find out about therapies in clinical development, efficacy rates, unmet needs, and future potential opportunities for pharmaceutical companies in the Crohn's Disease space.
Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Watch part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years and share the new methodologies and approaches required to deliver fresh insights in a rapidly changing environment.
Research Director, Peggy Yau, deep dives into South Korea's healthcare sector and explores how the structure in place can be used as a benchmark for most countries worldwide.
Wednesday 8th March 2023 marks International Women's Day, a global day of action aimed at accelerating gender equality and improving women's health. Asia-Pacific Director Wan Ling Neo reflects on why this is such an important issue in emerging markets.
Smart Analyst Syndicated Insights team has moved to Research Partnership
Research Partnership is delighted to announce that the Smart Analyst Syndicated Insights team has moved from Putnam to become part of the syndicated division of Research Partnership.
We are delighted to be co-presenting our paper ‘Under the skin of millennial physicians’ with Sanofi's Ana Claudia Alvarez at this year’s MRS Digital Ethnography Conference.
How we helped to identify the optimal pricing strategy and customer preferences in the diabetes space
Find out how we helped to identify the optimal pricing strategy and customer preferences which would affect demand for a novel product in the diabetes space.
We are delighted to be exhibiting and presenting at the Pharma Market Research Conference, 8-9 February in Newark, New Jersey. Representing Research Partnership will be Director and Head of our New York office, Liza Pliss as well as Director, Caroline Brennan, PhD.
How we helped to inform on the preferred business model(s), pricing and positioning for a Digital Pharma Solution (DPS)
Find out how we helped our client to understand current DPS purchasing practices in order to set pricing and contracting strategies that most strongly resonate with their customer base
Our client, who had built a new business unit for a vaccine product, needed a full programme of research to support and enhance their product’s pre-launch strategy, which would be delivered by a cross-functional team.
Research Partnership ranks 24th in the top 100 agencies
The UK’s best performing market research agencies were revealed this week with the publication of Research Live’s Industry Report for 2023, which includes the latest Market Research Society (MRS) League Tables.
Research Partnership and Bristol Myers Squibb win prestigious MRS Award
We are pleased to share the news that Research Partnership and Bristol Myers Squibb were pronounced the winners in the “Healthcare Research” category at the 2022 Market Research Society Awards.
We were delighted to attend and present a paper at the BHBIA winter seminar. This year's theme was 'Meet the Influencer … channels that are changing your customer’s behaviour'.
Mind the gap: Are digital health solutions really patient centric?
Is telemedicine beneficial for all healthcare conditions? Daniela Anselmi explains why now could be a good time for pharma to revisit the patient journey and address any satisfaction gaps that may be developing.
Last month, Anthony Greenwood attended the MRS Behavioural Science Summit in London which this year focussed on application in the both the online and offline settings as well as the metaverse.
Research Partnership and Bristol Myers Squibb win prestigious Quirk’s award
We are delighted to share the news that Research Partnership and Bristol Myers Squibb were pronounced the winner in the “Health Care / Pharmaceutical Research Project” category at the 2022 Quirk’s Marketing Research and Insight Excellence Awards.
After 2 years of virtual attendance, Emily Hoffman and Nirajana Tripathy joined over 200 attendees at the Intellus Worldwide Institute in person in New Jersey.
How to design a market research programme for a successful product launch
This simple guide outlines the key steps to creating a programme of research which will deliver the crucial insights for an effective marketing launch strategy.
Endometriosis: Hidden suffering and disease burden
Mariel Metcalfe & Nicole Syms share key insights from the 2022 Living with Endometriosis report, which highlights the pain and suffering experienced by those suffering from endometriosis.
How we helped to optimise the positioning for a new digital solution
Our client wanted to assess the target personas they should consider in order to enhance their lead generation and positioning for their digital solution.
We’re delighted to announce a Research Partnership study for a poster presentation at the ISPOR Europe 2022 conference, 6-9 November in Vienna, Austria.
Gene therapies for prevalent diseases in Europe – the perfect storm of economic sustainability?
In our latest pharmaphorum deep dive feature, Tania Rodrigues reached out to our payer network to understand the outlook for the gene therapy market access in Europe.
How we helped to ensure integration to the Alzheimer’s Disease pathway
Our client wanted to understand how best to engage with and support imaging centres and radiologists to ensure they are integrated in the Alzheimer’s disease care pathway.
The rise of patient influencers: What are the opportunities for pharma?
Paul Reed and Basil Fielding investigate patient online influencers and explain why pharma needs to monitor, join the conversation, and bring them into an engagement strategy.
How behavioural economics can help you build better brand communications
Roy Rogers investigates how we combine behavioral economics, implicit response testing, and AI eye tracking to create more impactful campaigns for our pharma clients.
Research Partnership welcomes intake of Research Graduates
Earlier this month, Research Partnership was pleased to welcome 5 new graduates to the UK office and 3 to the US offices in New York and San Francisco.
An interactive collection of case studies that outline how the views of patients, payers and physicians (and linked-choice modelling) can help you build an accurate picture of product uptake
New syndicated patient report - Living with Endometriosis
Our new Living with Endometriosis US report provides pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the endometriosis patient journey.
This animated case study shows an example of the types of insights our Living With patient reports reveal and how these syndicated reports can help companies who are striving to be more patient-centric.
Trends and opportunities in healthcare across emerging markets
Marc Yates explores shared characteristics, affordability, COVID-19 impact, AI and a wealth of other areas across emerging markets and how to maximise opportunities.
Discover how our syndicated patient reports based on quantitative and qualitative market research with patients, can provide you with comprehensive and cost-effective insight into the patient journey.
New syndicated patient report - Living with Uterine Fibroids US
This new Uterine Fibroids US 2022 patient report provides pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the patient journey.
Getting their lives back - improving options for people with lupus
Head of Therapy Watch, Helen Parfitt and Head of Living With, Mariel Metcalfe, investigate Lupus from the perspective of both healthcare professionals and patients using data from our syndicated products.
How we helped to gauge pricing and reimbursement expectations for a novel treatment in resource-limited settings
Read this case study to find out how we helped our client to understand the value drivers and reimbursement landscape for an infectious disease in order to guide the pricing of their novel treatment in the public and private channels
How we combined physician and payer perspectives to assess likely uptake in the future adult vaccine market
Read this case study to find out how we assessed the commercial value of a new adult vaccine and a new combination vaccine to inform clinical and commercial development.
COVID-19: Breaking down barriers to conducting qualitative research in China
Our experts collaborated with QualWorld ASIA, an independent qualitative fieldwork provider, to explore how qualitative healthcare market research has changed in China as a result of COVID-19.
Research conducted by Research Partnership published in leading medical journal
Findings from a study conducted by Research Partnership have recently been published in a leading medical journal, which provides stakeholders with the key data and opinions to make informed and specific decisions on clinical practice.
We outline our multi-country tracking study conducted with front-line HCPs reporting on both hospitalised and non-hospitalised patients across core global markets.
New syndicated patient reports - Living with PsA and AS US 2022
These new patient reports covering PsA and AS US 2022 provide pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the patient journey.
Brazil’s health-nutrition market: New clarity and cause for optimism
In this article, Paul Reed explores the nutrition market in Brazil and explains why it offers potential due to its more structured growth and transparent regulatory framework.
Research Partnership’s fieldwork team are 2022 BOBI award finalists
We are excited to announce that an entry submitted by Research Partnership’s fieldwork team for this year’s BOBI (Best of Business Intelligence) Awards has been highly commended and selected as a finalist in the ‘Creative Fieldwork Team of the Year’ category.
How behavioural science helped to uncover the drivers and barriers to product use
Find out how a range of behavioral science techniques enabled us to successfully identify the underlying influences on prescribing behaviours, both positive and negative.
Nutraceuticals in India – new impetus for health prevention
In this article, Paul Reed explores why the nutraceutical-market in India promises to be a dynamic new frontier in a market where COVID-19 has created new impetus for health prevention.
World EPA (Evidence, Pricing & Access) Congress 2022 round up
Rachel Howard, Tania Rodrigues, and Rebeca Nana Barrantes joined over a thousand delegates in attending the 2022 World EPA Congress in person in Amsterdam.
Research Partnership US employees awarded Intellus Young Professionals Grant
We’re delighted to announce that Stephanie Chell, Julia Jones, Jacob Berexa, and Nirajana Tripathy have all been awarded the Intellus Young Professionals Grant, enabling them to attend the annual conference later this month.
We have considerable experience in conducting market research for publications in peer-reviewed medical journals and for presentation at medical conferences.
New syndicated patient report - Living with Lupus US
This Lupus US patient report provide pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the Lupus patient journey.
We are delighted to announce the promotion of Tom Winter to Senior Director in our UK headquarters. Tom has 19 years of experience in global healthcare market research and consulting.
Understanding changing digital behaviours: Insights needed for an effective omnichannel strategy
In this webcast our experts from Singapore investigate changes in HCP and patients' online behaviours and share market research techniques to help build an effective omnichannel strategy and enhance digital engagement.
How behavioural science theory uncovered the insights required to improve vaccine uptake in the US
Read our latest case study to find out we used behavioural science to help our client understand the drivers and barriers of their vaccine in order to develop uptake solutions.
Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies
With our strategic insights, we are supporting the digital transformation of healthcare. In this new framework, containing assets, tools, and market research solutions, we help you find answers to the new business questions.
The rise, acceleration and acceptance of telehealth adoption
In our latest article for pharmaphorum Deep Dive, Marietta Fernandes, uses findings from our Digital Health Trends survey to summarise what we have learned about the rise of digital health tools since the start of the global pandemic.
Director Rachel Howard was recently interviewed by Julian Upton from Pharmaceutical Executive about the growth, threat and potential of the Chinese biotech industry.
Mexico’s drug market access landscape shake-up: What does it mean for pharma?
In the first issue of our new series, Access All Areas, Rebeca Nana Barrantes and Tania Rodrigues outline what the shake-up in Mexico’s drug market access landscape means for pharma.
How we identified the market opportunity for a minimally invasive weight loss device and procedure
Our client wanted to understand how their existing portfolio met the needs of the obesity and metabolic disease market and identify opportunities to improve and develop new products.
How we sized the market and mapped the patient journey across a rare hormonal disorder
Our client wanted to gain a better understanding of the Central Precocious Puberty (CPP) market in order to assess future opportunities for their hormone therapy.
The Market Research Society has published its annual League Tables and Research Partnership ranks 7th in the top 20 fastest-growing businesses and 12th in the top 20 fastest-growing individual agencies.
Webcast: Virtual Q&A session - The future of digital health
In this webcast, Senior Director, Richard Head and Director of The Medical Futurist, Dr. Bertalan Mesko host a live virtual Q&A discussion about the future of digital health.
How we helped characterise the injectable electrolyte and sterile water market landscape
Find out how we provided an understanding of the overall size of the injectable electrolyte and sterile water market, plus reveal the market share and key competitors within each individual molecule.
How we blended the principles of behavioural science with digital research techniques to track the launch of two new oncology therapies
Find out how we used a mobile methodology to gain valuable insights into the underlying, non-rational motivators that often underlie the rational, clinical reasons for prescribing.
Research Partnership makes 7 senior promotions and welcomes 2 new apprentices to its workforce
Research Partnership is delighted to announce a number of promotions in our UK and US offices, with 7 Associate Directors being promoted to Directors. We have also had the pleasure of welcoming 2 Project Management Apprentices who recently joined our UK office.
How an understanding of the patient journey helped support the pre-launch for a COVID-19 drug
Our client wanted to understand the COVID-19 journey Face mask- side view for HCPs and patients in order to inform the pre-launch activities / strategy for their antiviral drug.
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape look like?
Securing a future for telehealth with immersive market research insights
Watch this webcast, in which Director, An-hwa Lee and Associate Director, Marietta Fernandes investigate the current landscape, the challenges to adoption and the future for telehealth.
Nudging someone in the right direction isn’t always easy – that’s where behavioural science comes in
Dan Coffin outlines how behavioural science will help you to better understand the relationship and engagement that your stakeholders have with digital channels.
How we helped to inform the market access strategy for a new CAR-T therapy in multiple myeloma
Our client was developing a CAR-T therapy in Multiple Myeloma (MM) across multiple lines of therapy. Find out how we informed their market access strategy by identifying the key value drivers and optimal clinical trial design
How we uncovered unmet needs using a mobile app diary
Our client wished to assess the impact of the COVID-19 outbreak and subsequent lockdown on a chronic condition from the perspective of both people living with the condition and HCPs.
How we assessed demand and competition for a novel digital implantable therapeutic
Our client wanted to prepare a US forecast by demonstrating demand under specific clinical profiles for their implant product in the treatment of diabetes, identify the commercial contingencies and assumptions versus a competitor with an alternative method of administration.
How we helped a joint venture in the strategic development of a digital diagnostic tool
Research was needed to build an economic “theory” for the proposed solution, reactions to the concept, strengths and drawbacks, possible future improvements and potential pricing.
How we assessed the ongoing market opportunity for a digital health solution
Our client wanted to validate if their digital tool, which combined various features including a diagnostic element, delivered as an App, was still a good commercial fit compared with alternative options, looking at multiple therapy areas and various emerging markets.
Busting the myths of digital ethnography: How to generate rich, contextual, real-world insights remotely
Watch this webcast in which ethnography expert and qualified sociologist Mandira Kar will discusses all things digital ethnography with Associate Director, Nicky Barclay-Prout.
Accelerated digitisation can help aesthetics bounce back
Aesthetics experts Sarah Bangs and Paul Reed, discuss aesthetic medicine and digital media, and how accelerated digitalisation in this area presents an opportunity for pharma.
Is technology the answer to the mental health crisis?
An-hwa Lee explores the consequences on mental health as a result of the pandemic and how e-mental health solutions are on the rise in emerging markets.
Understanding changing digital behaviours: Insights needed for an effective omnichannel strategy
We investigate changes in HCP and patients' online behaviours and share market research techniques to help build an effective omnichannel strategy and enhance digital engagement.
The Future of Telemedicine: HCP And Patient Insights
We commissioned a self-funded qualitative study amongst ECPs (eye care professionals) and patients in US, Germany, and China to understand the opportunities and challenges for telemedicine solutions.
How we helped understand the customer journey and buying process in the neurodegenerative space
Our client was in the process of beginning trials for a new anti-sense therapy designed to specifically bind to the mRNA of a gene. The commercial team needed to fully understand the customer journey.
Breaking the silence: It’s time to talk about the menopause
October is World Menopause Awareness Month. In our latest article for PM Live, Vicki Newlove uses findings from our latest opinion poll to outline why the hidden landscape of menopause may finally be starting to change.
How we sought to understanding marketing to Millennial Physicians
Our client required us to develop an actionable communication & engagement road map based on a robust understanding of “Millennial Physicians’, as the future workforce.
How we helped optimize a Patient Support Programme (PSP) website and assess the need for a PSP Portal
Our client wanted to evaluate and optimize their PSP website prior to launch to ensure a streamlined user experience across HCPs and patients / caregivers.
View our animated video and discover how Therapy Watch can help you achieve a competitive edge through gaining an in-depth understanding of drug therapies, market shares over time, switching patterns and patient demographics.
Omnichannel marketing: the new template for customer engagement
Our experts discuss why pharma companies need to embrace creative thinking in response to new patterns of demand and create marketing strategies fit for a digitally enabled, consumer-oriented landscape.
How we helped determine the ideal omnichannel communication strategy
Find out how we helped our client achieve the best channel mix in terms of digital vs. traditional channels, and how use of each of these channels can be optimized.
How we helped to refine and optimise the positioning and pricing strategy for a migraine therapy
Our client wanted to refine and optimise their positioning and pricing strategy for Product X, used for the treatment of Chronic Migraine (CM) and Episodic Migraine (EM).
Respiratory medicine: Our experience and expertise
Download our complimentary infographic outlining the market opportunity as well as our experience and expertise in the growing area of respiratory medicine
The Living with team is attending the Patient Centricity and Engagement Conference 2021
We are delighted to be sponsoring and exhibiting at the conference on 9th September. Representing Research Partnership at the event will be Head of Living With, Mariel Metcalfe and Business Development Executive, Andie Vinycomb.
A glimmer of hope for Alzheimer’s patients, but at what cost?
In our latest article for PME Magazine, Rachel Howard reveals how EU payers EU payers reacted to the FDA’s recent approval of Aduhelm FDA through its accelerated approval pathway.
How we helped our client identify key messages for their allergy diagnostics in order to win in China
Find out how we helped our client to understand decision making in allergy diagnostics and perceptions of allergy testing platforms to inform their positioning and communication strategy in China.
Considerations for a patient centric telemedicine solution
An-hwa Lee reveals how telemedicine can help pharmaceutical companies offer their customers more patient centric solutions, including a case study in China.
Amplifying the patient voice: How to conduct patient research sensitively to uncover emotional insights
In this webcast, our APAC research experts, Wan Ling Neo and Colin Tan, share their experience of conducting research with patients with progressive or late-stage conditions and their caregivers.
How to embrace behavioural science principles in healthcare MR
Behavioural science is the scientific, evidence-based study of human behaviour in order to influence desired changes. Based on our expertise and experience, we have put together a guide on how to embrace behavioural science principles in healthcare market esearch.
Oncology landscape: How innovative market research methods can navigate you to success
In this webcast, Richard Head and Danielle Christmas, demonstrate how market research can deliver the insights needed to successfully launch in this increasingly complex and competitive environment
Therapy Watch has launched a tracker for COVID-19. This multi-country study will report on hospitalised and non-hospitalised patients across core global markets.
Driving and sustaining uptake of digital services in healthcare across APAC
In this article Colin Tan and Wan Ling Neo explore which digital services have excelled and where pharma need to monitor issues in order to drive and sustain uptake.
We surveyed a wide range of physicians in the US, Europe and China to answer key questions about the impact of COVID-19 on the use of digital health tools
We’re delighted to announce that a study carried out on behalf of Janssen Pharmaceuticals was selected by the American Society of Clinical Oncology for an e-poster presentation at the ASCO Annual Meeting in June 2021
We were delighted that a Research Partnership study into the burden of illness in newly diagnosed Multiple Myeloma patients & their caregivers was selected for an e-poster presentation at the EHA 2021 Virtual Congress.
How we adapted our conference research to a virtual setting to measure performance and reactions
Our client was presenting and exhibiting at the ESC virtual congress and wanted to understand reactions to and impact of their data as well as perceptions of the digital experience.
How to improve payer engagement with tailored value communication
In this article for pharmaphorum, Cecilie Alstad, Senior Analyst, discusses how an approach established in the world of marketing and commercial strategy could be the key to significantly improving pharma’s payer engagement.
We’re delighted to announce a Research Partnership study into the burden of illness in newly diagnosed Multiple Myeloma patients & their caregivers has been selected for an e-poster presentation at the EHA 2021 Virtual Congress.
An-hwa Lee, Director, will be co-presenting ‘Finding a focus for telemedicine: Visionary patient opportunity or short-sighted solution?’ with Karen Sheehan, Insights and Analytics Business Partner at Novartis
We were delighted to present an online panel at this year’s BHBIA Virtual Conference. Associate Director Vicki Newlove hosted ‘Leading Perspectives: Digitalisation and the Future of Healthcare’
The disparity of patient experiences with Crohn’s Disease in Europe and Japan
Head of Living With, Mariel Metcalfe, discusses the market differences regarding the patient experience of those living with Crohn’s in the EU vs Japan, using data from our syndicated reports.
Another emerging ethical minefield in the Covid-19 vaccine arena: behavioural science and the use of incentives to boost acceptance
Rachel Howard explores whether the role of behavioural science in the design of effective public health messaging and strategies can help encourage uptake of vaccination.
In this webcast, quantitative experts Rebecca Davies and Richard Newman, will utilise their knowledge and experience of conducting global segmentations for pharma, to explore a range key segmentation challenges.
Influencing HCP behaviours – Is now the perfect opportunity?
In this webcast, our behavioural science Directors, Dan Coffin and Anthony Greenwood, demonstrate how to put behavioural science at the forefront of market research and deliver insights that drive demonstrable impact on physician and patient behaviour during this time of great change.
The positive impact of technographic profiling on omnichannel marketing
Marc Yates discusses why technographic profiling should be understood and used by pharma in order to engage their target customers in an increasingly digital world.
Golden opportunity for digital healthcare: the silver surfers in emerging markets
Digital and emerging market specialist, An-hwa Lee, discusses how and why the elderly population is increasing their engagement with digital technology.
Research Partnership and Bristol Myers Squibb are 2021 BOBI Award finalists
We are excited to announce that two of Research Partnership’s submissions for this year’s BOBI Awards have been highly commended in both the ‘Best Patient-Centric Approach’ and ‘Analyst Team of the Year’ categories.
Associate Director Vicki Newlove will be hosting ‘Leading Perspectives: Digitalisation and the Future of Healthcare’, a live panel thought-leadership debate at the BHBIA Virtual Conference 2021.
World EPA (Evidence, Pricing & Access) Congress 2021 round-up
Earlier this month several members of Research Partnerships Market Access team, including Directors Brett Gardiner and Rachel Howard, joined over 1000 global delegates attending the virtual World EPA Congress.
Did you know that we have conducted over 200 market research projects in China? Find out our top 10 tips for conducting research in this exciting region.
Amplifying the patient voice: How to conduct patient research sensitively to uncover emotional insights
In this webcast, our research experts, Ellie Forde and Zoe Callaghan, share their experience of conducting research with patients with progressive or late-stage conditions and their caregivers.
Quantitative specialist joins Research Partnership, London
Roy Rogers joins the US Division of the company as a Quantitative Director, bringing with him much experience in a breadth of different research techniques.
Chronic Venous Diseases patient journey 2020: Servier publishes key findings of a global market research study conducted by Research Partnership
A major survey carried out in five key representative countries (Brazil, China, Czech Republic, Italy and Russia) has recently been published on Servier’s website with the aim of supporting people with Chronic Venous Diseases (CVD).
COVID-19 vaccine pricing post pandemic - Payers' expectations
Rachel Howard and Suzan Serip outline why “In pandemic” pricing has not followed the usual market mechanisms for vaccine pricing and how payers expect vaccine prices to evolve once we emerge from the current crisis.
Small populations, big challenges: How to conduct quantitative research in rare diseases
We'll explore some of the key challenges of conducting rare disease market research and demonstrate how to overcome them using a range of small sample analytical techniques
Digital-Communication Check: Insights Learned During Lockdown
Marketing Director, Julie Denny looks at the results of recent surveys revealing the impact of the COVID-triggered digital switchover on sales rep interactions and medical conferences.
Every voice counts in MedTech – Getting more with less via a robust trade-off technique
In this webcast our research experts, Sabera Hyderally and Kristin Lovallo consider the practical benefits of SIMALTO and share a case study with a demo of a survey.
Agility happens when there is fluid and effective collaboration between researcher and client. Based on our expertise and experience, we have put together a guide on how to conduct effective agile research.
How we adapted our conference research to a virtual setting to measure performance and reactions
Our client was presenting clinical trial data for their cardiovascular product and were also exhibiting a virtual booth at the ESC (European Society of Cardiology) Congress 2020 – The digital Experience.
Emilie Braund and Harrison Gaiger dig down into the top insights pharma companies can harness to make their patient support programmes as powerful as possible.
The power of a good story: Turn your insights into effective storytelling with data visualisation
Julie Denny, Jamie Laidlaw and Amanda Brent share their approach to data storytelling with the use of a range of interactive tools and creative outputs.
3 innovations booming during COVID and how to adopt them successfully
Vicki Newlove explores research into digital change during COVID-19 to find out what business questions pharma needs to address to succeed with innovations.
Understanding the impact of Anaemia among people with CKD: a condition that is unrecognised and underappreciated
Head of “Living With”, Mariel Metcalfe and Associate Director Beth Clark, discuss the nature of Anaemia in CKD, treatment options and unmet patient needs.
This multi-country study reports on patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) across core global markets and is available to purchase.
Our emerging market experts highlight how we can help you maximise your competitive advantage in the markets offering the best opportunities for growth.
World Pharma Pricing Market Access & Evidence Congress 2020
Last month, several members of Research Partnership’s specialist market access team, including Directors Brett Gardiner and Rachel Howard, attended the virtual World Pharma Pricing Market Access & Evidence Congress.
Research Partnership welcomes 12 new graduates for 2020
Research Partnership recruits a new intake of 9 Research Analysts and 3 Fieldwork Project Coordinators into our annual market research graduate programme.
Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma
Head of “Living With”, Mariel Metcalfe, discusses the nature of severe asthma and severe eosinophilic asthma, and some key findings from recent studies.
This infographic displays our experience and expertise in delivering global market research insights in user experience, with links to a range of resources.
Keeping up with the Coronavirus: Monitoring the impact of COVID-19 on the market access landscape
Our market access team share insights from our COVID19 study and advise how biopharmaceutical companies can keep up with pricing and market access activity.
UX research enables companies to understand user behaviours, needs and motivations for engaging with digital assets through observation techniques and task analysis. This guide shows you how to get the insights you need to allow you to improve the user experience.
Digital qualitative research, the evolving digital landscape and our project experience with relevant case studies using digital methods in emerging markets.
How will COVID-19 affect the financing of healthcare provision across the US?
Using findings to assess the impact of COVID-19 on biopharmaceutical market access, George Forsyth explores the economic impact to the US healthcare system.
How we assessed the access potential of a new product in order to develop a successful launch strategy
Our client had two regimens in clinical development for the front-line treatment of an oncology condition using a breakthrough product; and planned to release outcomes data at key industry events.
How we helped our client maximise uptake and fine-tune the marketing strategy for their vaccine product in China
Our client’s vaccine to protect against a condition prevalent in older adults had recently launched, they wanted to understand more about their target healthcare consumer and attitudes to health, well-being and vaccination.
New patient syndicated reports - Living with Ulcerative Colitis and Crohn's Disease 2020
These patient reports provide pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the UC and CD patient journeys and are available to purchase.
Breaking policy and perceptual barriers: Biosimilars
Pharmaphorum Deep Dive: Analysis of RA prescribing data to identify how market access policies across Europe may have impacted the adoption of biosimilars.
Not just another PSP: 5 top tips for evaluating your patient support programme
Evaluating PSPs before launch is critical. We present you with our top tips for conducting successful market research to ensure your PSP is successful and maximises value to your customers.
How we conducted conference research to to understand physician’s reaction to the abstracts presented in a virtual setting
Our client had planned to present new scientific data from its growing oncology portfolio and research pipeline at the Annual Meeting of The American Society of Clinical Oncology (ASCO).
How we supported forecasting for a new vaccine by identifying the optimal pricing strategy
Our client was looking to identify the price point that would maximise revenue from their new vaccine across 8 emerging markets in Latin America and Asia Pacific, as well as establish long-term projections for their forecasting model.
We are delighted to be exhibiting at the virtual 2020 Intellus Worldwide Summit from 9th-10th June. Representing Research Partnership at the event will be Emily Hoffman, Associate Director.
Research Partnership publishes new patient syndicated reports - Living with Severe & Eosinophilic Asthma US, Japan, 2EU
These patient reports provide pharmaceutical companies with up-to-date insights on the severe and eosinophilic asthma patient journey in the US and Japan and are available to purchase.
Rachel Howard takes a look at how the pharmaceutical industry is portrayed in Hollywood films and asks the question, is now the time for pharma to take back control of the narrative?
How we conducted rare disease patient research during the COVID-19 lockdown in China
Our client needed to conduct a small number of qualitative interviews in China with patients diagnosed with a rare condition which affects children and young adults. The results of the survey were time critical as they were needed to inform a protocol being published in 30 working days.
How to create a market research programme for an effective product launch
This simple guide is aimed at helping companies who don’t have their own in-house research team. It outlines the key steps to creating a programme of research which will deliver the crucial insights for an effective marketing launch strategy.
Research Partnership publishes new patient Living with Anaemia in CKD EU & US reports
These patient reports provide pharmaceutical companies with up-to-date insights on the Anaemia in CKD patient journey in the EU and US and are available to purchase.
How we used online bulletin boards and an advisory board to help our client understand the dynamics of the payer environment
Our client had a product for the treatment and prophylaxis of bleeding in patients with Haemophilia A. Although the market had been stable, it was expected to change somewhat significantly as new products were due to be launched.
Research Partnership ranks in top 25 UK market research agencies
Research Partnership ranks 23rd in the top individual agencies and is the UK's largest individual healthcare consulting specialist in the UK MRS League Tables 2020 published by Research Live.
How an online market research community delivered fresh insights into a small and hard-to-reach audience
Our client needed to research an extremely small and difficult to reach audience in multiple markets across the globe in support of their new product in development.
Earlier this month Director, Head of NY Office, Liza Pliss and Director, Head of Philadelphia Office, Head of MedTech Division, Sabera Hyderally attended the Pharmaceutical Market Research Conference in Newark, New Jersey.
How we used WhatsApp and projective exercises to capture deep emotional insights into people living with HIV in South Africa
Our client wanted to identify and profile different segments of people living with HIV in order to understand key barriers and leverage points and ensure future engagement with their pharmaceutical portfolio.
Latin America has diverse and unique healthcare systems, an ageing and declining population, and a rise in the popularity of digital communication channels, especially WhatsApp.
Rachel Howard and expert Dr Xavier Tello discuss the latest changes in the healthcare system and consider what they mean for pharmaceutical manufacturers.
How were the teenies? Reflecting on global healthcare and market research over the last decade
Read this interesting article by market research expert Rachel Howard, in which she reflects on global healthcare and market research over the last decade.
Earlier this month Senior Director Angela Duffy and Director Dan Coffin attended the European Pharmaceutical Market Research Conference in Basel, Switzerland.
“Alexa, process this data for me” 3 ways the AI evolution is redefining how we collect market insights
In this article first published in PME magazine, Marketing Manager Harrison Gaiger outlines the three ways AI is redefining how we collect market insights.
All eyes on Spinraza - What does Brazil’s unprecedented risk-sharing agreement in SMA mean for the future of market access in Brazil?
Director Rachel Howard asks, “What does Brazil’s unprecedented risk-sharing agreement in Spinal Muscular Atrophy (SMA) mean for the future of market access in Brazil?
How we helped our client identify where to play and how to win for their hospital product in India
Our client wanted to understand which channels they should focus on (where to play) and what points of differentiation would enable them to gain market share in those chosen channels (how to win).
On 11th September, Director, Phil Rosenberg and about 60 other delegates attended the first Intellus regional event hosted in the beautiful Chicago Botanical Gardens.
Engaging patient advocacy groups: The key to conducting effective rare disease research
This article, published by Pharma Times September 2019, outlines why market researchers should reach out to patient advocacy groups when conducting rare disease research.
How we helped our client assess the asthma market landscape in emerging markets
Our client was jointly developing a fully-human monoclonal antibody (mAB) with a number of potential immunological indications. Research was required to further understand the asthma landscape.
How integrated insights supported a biologic launch strategy across multiple indications
Our client launched a new biologic in immunology across several indications and wanted to understand the market, including treatment landscape and pricing opportunity.
How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market
Our client wanted to understand what the current and future combination pricing strategies were for oncology products, with a focus on MM and their product.
Research Partnership welcomes new hires in our UK headquarters
Rebeca Nana Barrantes has joined the Market Access team as an Analyst. Alicia Crawley joined as Research Executive. Cristina Cunat Fernandez also joined the UK office as Quantitative Research Executive.
Game changer: The role of immersive technologies in the healthcare and pharmaceutical industries
This article, published by Med Ad News August 2019, explores how technological advances in VR/AR are offering new opportunities for conducting healthcare market research.
How we used Conference Live at a series of large and small-scale congresses to measure shifts in customer perceptions over time
Our client planned to have a significant presence at a variety of large and small-scale medical congresses in both the US and EU in support of their portfolio of products for a range of degenerative neurological conditions.
How a mindset-based customer segmentation was developed to drive engagement with physicians in oncology
Our client wished to develop an attitudinal mindset-based customer segmentation. This would allow for clear identification of each segment in the field; effective deployment of the sales force at launch by prioritising segments that show the greatest opportunity.
Like, like, like: Harnessing the power of social media insights
Given the colossal amount of personal and professional information that we share online, social media channels such as Facebook and Twitter are fast becoming treasure troves of big data. Harrison Gaiger explores how pharmaceutical companies can utilise social media insights.
How a combined qual quant approach provided our client with integral insights for continued product development in the HIV space
Our client was looking to develop novel HIV prevention products, and wanted to explore different formulation options. They wanted to learn both the reactions to the novel formulations as well as the impact of out-of-pocket (OOP) costs.
Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports
These syndicated patient reports provide detailed insights into the patient journey for people living with AS and nr-Ax SpA and are available to purchase.
Andrew has 19 years of healthcare market research experience and joined Research Partnership as a graduate in 2000. Over the years he has made a significant contribution to the success of the company, both from a research perspective and in terms of providing management and leadership support.
Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)
In this study, 40 dermatologists in major EU markets report every quarter on patients on advanced therapies including biologics and small molecule therapies.
Fast and furious - What will the fast tracking of approvals for key drugs mean for China's pharma market?
Expanded access to state-funded healthcare, population aging and a growing burden of chronic disease are creating new opportunities. Pei Li Teh asks, What will the fast tracking of approvals for key drugs mean for China's pharma market?
The Promise and Pitfalls of Molecular Testing in Oncology
Dr. Chris Gaj explores the challenges and potential consequences for stakeholders in the US, Europe and emerging markets in the latest issue of pharmaphorum's Deep Dive.
Richard Head presented with award at EphMRA Conference
Research Partnership exhibit, sponsor and present three papers at the EphMRA conference where Director Richard Head was presented with the runner-up award for ‘Business Impact through Innovation’ 2019.
How patient insights were brought to life with graphic novel outputs
Our client was developing a novel therapy for the treatment of a rare disease in which patients suffer acute symptomatic attacks, they requested that insights from the research, particularly patient research, were brought to life in the insights workshop meeting in a new and impactful way.
Hyperlipidemia: Are the PCSK9 inhibitors bouncing back?
This article, published by Pharma Times May 2019, considers the current landscape for PCSK9 inhibitors and whether there is a brighter future on the horizon for this class of drugs.
Research Partnership and Janssen awarded runner-up in the EphMRA MR Excellence Awards
An entry submitted by Janssen and Research Partnership for the 2019 EphMRA MR Excellence Awards awarded runner-up in the ‘Business Impact through Innovation’ category.
How Paediatricians and GPs revealed key insights to help develop a science story for a child nutritional supplement
Our client wanted to define the patient target, frame the challenge of growth delays to be an effective call to action, articulate objectives for the product and the best way to express its value proposition.
Our emerging markets team has considerable expertise conducting research in South East Asia, with our Asia headquarters located in Singapore, we can support your market research needs.
World Immunisation Week: Combating the rise of the anti-vaccination movement
Harrison Gaiger explores the rise of the anti-vaccination movement to understand what it has meant for global health, and outlines some of the initiatives that are aiming to combat vaccination hesitancy.
Boon Yap joins Market Access UK, Megan Armano joins as Senior Research Executive, US Philadelphia, Berengere Pate joins as Research Manager, Lyon office.
How we helped our client to understand the opportunities across Asia and other emerging markets using interactive outputs
Our client wanted to understand the diabetic patient journey in order to assess the opportunities to expand HCP knowledge on the importance of lipid lowering for type 2 diabetes patients.
Earlier this month, Director, Head of New York office, Liza Pliss and Associate Director, Emily Hoffman attended the Pharmaceutical Market Research Conference in Newark, New Jersey.
How we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment
Our client's objective was to successfully launch their product in order to provide clinically meaningful benefits to patients and contribute to the overall growth of their business.
How we helped track and evaluate conference performance over time across multiple international events
Our client was developing a portfolio for the treatment of a chronic neurodegenerative disease and planned to have a significant presence at key neuroscience conferences over the coming year.
How to conduct pharma market research in emerging markets
Using our combined knowledge and years of experience of working in these territories, our emerging markets experts have produced this essential desktop guide.
Earlier this month Director Paula Coyle and Associate Director An-hwa Lee attended the European Pharmaceutical Market Research Conference in Basel, Switzerland.
How we used behavioural economic theory to reveal fresh insights into patient compliance
Our client currently has a product for a chronic rare disease which has seen an initial successful uptake. HCPs appear to support the product and are actively prescribing it to suitable patients.
A common reality: How augmented reality is transforming the future of pharmaceutical marketing
Second installment exploring virtual and augmented reality, Harrison Gaiger explores the ways in which AR is transforming the future of pharma marketing
How we facilitated mock negotiations with payers to improve the pricing strategy for a new biologic in Latin America
Our client wanted to understand how they should manage payer objections within the value proposition, clinical evidence and economic value of the product.
How we assessed payer perceptions of a new therapy for Atopic Dermatitis in emerging markets
Our client was developing a product for use in Atopic Dermatitis (AD); and wanted to understand how best to position this product in order to optimise pricing and market access.
How to conduct research for scientific publication
Based on our expertise and experience of conducting market research for scientific publication in both developed and emerging markets across a wide range of therapy areas, we have put together a guide on how to establish medical credibility with your research.
How we evaluated the potential for an existing AI product to treat a rare disease
Our client wished to explore the opportunities for using their drug to treat another more low-prevalence orphan disease where there is no current targeted treatment available.
How conference research was used to gauge reactions to new clinical data
Our client had recently conducted a series of clinical trials with its breakthrough cardiovascular product, resulting in outcomes data which had the potential to give it a more competitive edge and successfully differentiate it against their closest competitor.
How we assessed the opportunity for a rare disease product in emerging markets
Our client had a product indicated for a rare Haematology disease. Whilst this product was successfully launched in over 40 countries globally, it had a limited presence in many emerging markets.
How interactive workshops supported the development of an automated compounding system
Our client was developing a new to market automated compounding system for the TPN market. Research was required to assess what customers needed vs. what they desired.
Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia.
Janssen & Research Partnership win prestigious BHBIA Best Business Impact award
Janssen and Research Partnership win the 2018 BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference for our collaborative market research and consultancy work.
How published research underpinned a cancer therapy awareness campaign
Our client markets a product for Oral Mucositis (OM) - a side effect of cancer treatment - and wanted to better understand the disease and treatment challenges faced by both patients and physicians across Asia.
How we helped our client reverse it's fortunes with a colourful segmentation
Our client wanted to develop a mindset-centered customer segmentation to support the launch of a product in the treatment of CLL and MCL within their haematology franchise.
Research Partnership is delighted to be attending the ESOMAR conference in Bangkok 13-15 May. The theme of this years’ conference is DRIVE: Data Research Insights Vision Excellence.
How buyer insights supported the development of an effective market strategy
Our client was developing a new product for HIV and needed to understand buyer willingness to pay in the emerging markets of South Africa, Kenya, and India.
How a hybrid approach delivered fast insights to feed into an oncology product’s adoption strategy
Our client wanted to quantify how ovarian cancer patients are managed prior to product launch, but also needed to understand why patients do or do not receive key diagnostic tests or therapies. Time constraints limited the ability for a full qualitative phase.
How research supported the design of a support console to drive new product uptake
Our client wanted to discover physicians’ suggestions for the current prototype console and the potential barriers and drivers that may affect uptake, prior to initiating full development of the system.
How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market
Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led by established 1st generation tyrosine kinase inhibitors (TKIs).
How we evaluated the patient value for a new insulin pen
Our client markets a range of pen devices to deliver insulin to diabetes patients. They had developed a new feature for one of their current devices and wished to evaluate the utility of this feature to help understand if further refinement and development was required.
In this article by Rachel Hard, published in Pharma Exec, she discusses the huge number of new opportunities for pharma companies in the emerging markets
Medical Marijuana: A Challenge to Traditional Pain Relief?
In this article, we discuss the medical use of marijuana for a broad range of conditions expanding rapidly in the US, as legalization gathers pace and investors flock to a booming market.
Director Richard Head outlines how we used facial analysis to understand physicians’ response to communications materials designed for a disease awareness campaign.
How facial analysis was used to evaluate the emotional impact of a disease promotion campaign
Our client had developed a visual and emotion-invoking, online disease awareness campaign aimed at challenging physicians’ current perceptions of treatment. They wished to understand physicians’ reactions to the campaign (rational and emotional).
Rachel Howard discusses the opportunities in the markets of Mexico, Indonesia, Nigeria and Turkey. These are the countries poised for strong economic growth, like the emerging markets of BRIC (Brazil, Russia, India and China) before them.
The value of design thinking: Incorporating creative and graphic design into pharma market research
How do we keep research design fresh and interesting? How do we ensure that we’re inspiring our respondents to give us enlightening new insights, and encourage new ways of thinking? This blog explores.
Marc Yates discusses the changing demographic features in Asia, which are set to have profound repercussions on the continent’s socio-economic and healthcare set-up in the coming decades.
How brainstorming exercises enhanced a segmentation validation study
Our client had an oncology product in development for the treatment of prostate cancer, they wanted to conduct research to inform future planning, list development, advisory board creation, and initial communications platforms.
How conjoint was used to determine the optimum features for a BGM device
Our client wanted to determine the optimal new blood glucose monitoring device – one that would best retain their current customers and also attract new ones. They also wanted to be able to rationalise the strengths of their existing portfolio against their competitors.
In this article we look at South Korea’s healthcare outlook in more detail, and ask why the country lies at the extremes of two conflicting global health indicators – longest life expectancy and highest suicide rates.
Research Partnership celebrated 20 years in business this year with expansion across the U.S., opening new offices in San Francisco and New York. We shine a light on four of our key faces of research.
How statistical analysis revealed the most effective segmentation solution for an established product in multiple indications
Our client has an established product for multiple indications. They wanted to create a HCP segmentation typing tool which could be implemented in-field to help classify physicians across two different therapeutic areas.
How wargaming was used to understand the likely future HCV landscape and give strategies for brand success
Our client wanted to conduct research in order to feed into strategy development for their product and find out what would physicians think of the new entrants and how could this be leveraged to ensure a successful launch.
We were delighted to exhibit and present a paper at the Pharmaceutical Market Research Conference 13-14 June in Bay Area close to our new office in San Francisco.
How gamification and advanced analytics gave big pharma the insights to optimise their global corporate image
Our client’s senior management wanted to assess its company’s image amongst their key HCP stakeholders. The client wanted to measure familiarity and perceptions of the company versus its competitors, particularly in light of recent corporate announcements.
Deep Dive: Using market research to facilitate patient centricity
In this article, we look at the factors that have come together in recent years to drive a transformation within pharmaceutical companies from being product-led to patient-centric.
This animation outlines how we use the art of storytelling using data visualisation techniques to bring to life the key insights from market research findings.
Access and elimination: the future of DAAs in Hepatitis C
Associate Director, Conor O’Kane, analyses data collected by Therapy Watch HCV, an online study of patient record forms collected each quarter from 335 physicians across nine European markets and Canada.
How qualitative insights were used to help shift perceptions of the use of probiotics in IBS Management
Our client wanted to uncover potential leverage points to build a strong storyline and communication strategy for their product, which would encourage healthcare professionals to recommend its use to their patients.
Telehealth research - The remote exchange of data between patients and their clinician
Technology is helping patients become more engaged in managing their own health and manufacturers are keen to leverage these new opportunities in order to improve delivery of care.
How qualitative research was used with payers in low and middle income countries for an Acute Heart Failure (AHF) drug
Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in low and
.png?length=600&name=Reviewing%20data%20(shutterstock_161596499).png)
.png?length=600&name=Spotlight%20on%20MG%20(2).png)
.png?length=600&name=UC%20spotlight%20image%20Feb%202023%20(2).png)
.png?length=600&name=Spotlight%20on%20CD%20image%20(2).png)
.png?length=600&name=shutterstock_1583416510%20(1).png)
.jpg?length=600&name=Omnichannel%20marketing%20webinar%20for%20zoom%201%20(2).jpg)
.png?length=600&name=Endometriosis%20(6).png)
.jpg?length=600&name=27616%20Product%20Launch%20Linkedin%20RP%20post%204%20OPT2%20v2%201%20(002).jpg)
.png?length=600&name=shutterstock_1029741865(1).png)
.png?length=600&name=Endometriosis%20(4).png)
.png?length=600&name=LW%20AS%20(2).png)
.png?length=600&name=LW%20AS%20(2).png)
.png?length=600&name=Market%20research%20website%20image%20(1).png)
.png?length=600&name=Screenshot%20(45).png)
-2.png?length=600&name=Screenshot%20(38)-2.png)
%20Researching%20beyond%20the%20website/UX%20Sep%20webinar%20image%20.jpg?length=600&name=UX%20Sep%20webinar%20image%20.jpg)
.jpg?length=600&name=Every%20voice%20counts%20in%20MedTech%20%E2%80%93%20Getting%20more%20with%20less%20via%20a%20robust%20trade-off%20technique%20(Jan%202021).jpg)
.jpg?length=600&name=Combination%20therapies%20in%20Oncology%20(May%202018).jpg)
.jpg?length=600&name=Harnessing%20the%20power%20of%20social%20(Aug%202019).jpg)
.png?length=600&name=MRX%20time%20machine%20(June%202019).png)
.jpg?length=600&name=UX%20(June%202019).jpg)
.jpg?length=600&name=Navigating%20new%20frontiers%20(March%202019).jpg)
.jpg?length=600&name=Rheumatoid%20arthritis%20(RA).jpg)
.png?length=600&name=Poker%20face%20(Jan%202019).png)
.jpg?length=600&name=Oncology%20in%20APAC%20(Jan%202018).jpg)
.jpg?length=600&name=Optimise%20your%20digital%20assets%20with%20UX%20(Oct%202018).jpg)
.jpg?length=600&name=Nurtionals%20(Feb%202018).jpg)
.jpg?length=600&name=Patient%20centricity%20(March%202017).jpg)
.png?length=600&name=Going%20for%20growth%20in%20emerging%20markets%20(Oct%202017).png)
.jpg?length=600&name=Capturing%20the%20%E2%80%9Cmoments-of-truth%E2%80%9D%20(Aug%202017).jpg)
.jpg?length=600&name=Womens%20health%20in%20EMs%20(July%202017).jpg)
%20drug-%20case%20study.png?length=600&name=How%20qualitative%20research%20was%20used%20with%20payers%20in%20low%20and%20middle%20income%20countries%20for%20an%20Acute%20Heart%20Failure%20(AHF)%20drug-%20case%20study.png)